Share
Journal Information
Issue
Vol. 32. Issue 5.Pages 183-230 (September - October 2020)
Originals
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU)
Lluís Masana, José López Miranda, Fernando Civeira, Leonardo Reinares, Carlos Guijarro, Núria Plana, Rafael Cuenca, Demetrio Sánchez, ... Santiago Villamayor
Clin Investig Arterioscler. 2020;32:183-92
Open access
Open Article
Effect of clopidogrel vs. aspirin on pro-atherosclerotic NLRP1 inflammasome expression in endothelial cells. ECLOAS study
Silvia Bleda, Joaquin de Haro, Isabel Sánchez, Ilsem Laime, Francisco Acin
Clin Investig Arterioscler. 2020;32:193-9
Full text access
Open Article
Association between non alcoholic fatty liver disease, metabolic and vascular risk
Iker Elosua-Bayés, Óscar Beloqui Ruiz
Clin Investig Arterioscler. 2020;32:200-5
Full text access
Open Article
Editorial
Cardiovascular risk, Metabolic disease and NASH control for Health Empowerment: Future endeavours
Diego Martínez-Urbistondo, Jose María Argemí Ballbe, Jose Alfredo Martínez
Clin Investig Arterioscler. 2020;32:206-8
Full text access
Open Article
Special article
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias
Juan Pedro-Botet, Juan F. Ascaso, Mariano Blasco, Ángel Brea, Ángel Díaz, Antonio Hernández-Mijares, Xavier Pintó, Jesús Millán
Clin Investig Arterioscler. 2020;32:209-18
Full text access
Open Article
Consensus document
Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®)
Xavier Pintó, Luis Masana, Fernando Civeira, José Real, Daiana Ibarretxe, Beatriz Candas, José Puzo, José Luis Díaz, ... Pedro Valdivielso
Clin Investig Arterioscler. 2020;32:219-29
Open access
Open Article